Cardiovascular diseases (CVDs), such as ischaemic heart disease, cardiomyopathy,
atherosclerosis, hypertension, stroke and heart failure, are among the leading causes of …

The prevalence of heart failure is on the rise and imposes a major health threat, in part, due
to the rapidly increased prevalence of overweight and obesity. To this point …

Ethnopharmacological relevance Diabetes and hypertension are pathophysiologically
related diseases that co-exist with a wider complex of metabolic diseases having similar set …

Type 2 diabetes mellitus (T2D) contributes to sustained inflammation and myopathic
changes in the heart although the precise interplay between the two remains largely …

The prevalence and severity of obesity, type 2-diabetes, and the resultant metabolic
syndrome are rapidly increasing. As successful preventive and therapeutic strategies for …

Type 2 diabetes mellitus (T2DM or T2D) is a devastating metabolic abnormality featured by
insulin resistance, hyperglycemia, and hyperlipidemia. T2D provokes unique metabolic …

Type II diabetes mellitus (T2DM) is a fast‐growing epidemic affecting people globally.
Furthermore, multiple complications and comorbidities are associated with T2DM. Lifestyle …

Heart failure is one of the major causes of mortality worldwide and it is the end stage of
several cardiovascular diseases. Traditional Chinese medicine has been used in the …

Tetramethylpyrazine (TMP), a pharmacologically active component isolated from the
rhizome of the Chinese herb Rhizoma Chuanxiong (Chuanxiong), has been clinically used …

Hypoglycemic activity‐guided separation of ethanol extracts from the fruits of Cornus
officinalis Sieb. et Zucc (CO) led to the isolation of loganin, morroniside, and ursolic acid …